Enact Holdings, Inc. (NASDAQ:ACT) has entered into a quota share reinsurance agreement, under which it will cede 13.125% of a portion of current and expected new insurance written for the period from January 1, 2023 through December 31, 2023. Since 2015, Enact has executed approximately $4.7 billion of Excess of Loss CRT transactions, including reinsurance coverage of approximately $2.9 billion with highly rated reinsurers.